The purpose of this study is to assess the immediate and long-term effects of structured breathing on clinical symptoms related to mental health including anxiety, depression, perceived stress, and sleep quality.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
15, 30, or 36 minute structured breathing sessions based on personal skill level.
Mayo Clinic Health System-Albert Lea
Albert Lea, Minnesota, United States
ACTIVE_NOT_RECRUITINGMayo Clinic Health System-Mankato
Mankato, Minnesota, United States
ACTIVE_NOT_RECRUITINGMayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, United States
RECRUITINGAssess feasibility of the structured breathing-based intervention among healthcare professionals via ease of recruitment
This outcome measure will assess whether the structured breathing-based intervention is feasible among healthcare professionals via ease of recruitment reported by study staff.
Time frame: Enrollment to end of study participation at 4 months.
Assess feasibility of the structured breathing-based intervention among healthcare professionals via retention statistics
This outcome measure will assess the feasibility of the structured breathing-based intervention among healthcare professionals by examining retention rates throughout study duration.
Time frame: Enrollment to end of study participation at 4 months
Assess feasibility of the structured breathing-based intervention among healthcare professionals via mobile app engagement metrics
This outcome measure will assess whether the structured breathing-based intervention is feasible among healthcare professionals by analyzing app usage metrics from participants.
Time frame: Enrollment to end of study participation at 4 months
Assess feasibility of structured breathing-based intervention among healthcare professionals via Feasibility of Intervention Measure
To assess the feasibility of a structured breathing intervention among healthcare professionals using Feasibility of Intervention Measure (FIM). Feasibility of Intervention Measure is a four-item measure of implementation feasibility with scores ranging from 1-5, with higher scores indicating greater feasibility.
Time frame: Enrollment to end of study participation at 4 months
Assess appropriateness of structured breathing-based intervention among healthcare professionals
To assess the appropriateness of a structured breathing intervention among healthcare professionals using Intervention Appropriateness Measure (IAM). Intervention Appropriateness Measure is a four-item measure with a scale of responses from 1-5, with higher scores indicating greater appropriateness.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mayo Clinic Health System-La Crosse
La Crosse, Wisconsin, United States
ACTIVE_NOT_RECRUITINGTime frame: Enrollment to end of study participation at 4 months
Assess acceptability of structured breathing-based intervention among healthcare professionals
To assess the acceptability of a structured breathing intervention among healthcare professionals utilizing the Acceptability of Intervention Measure (AIM). Acceptability of Intervention Measure is a four-item measure with responses from 1-5, with higher scores equating to greater acceptability.
Time frame: From enrollment to the end of study participation at 4 months
Assess participant satisfaction related to breathing-based intervention
Participant satisfaction will be assessed through a mixed-methods approach combining quantitative surveys (exit survey) and qualitative participant interviews (4 month in-person visit/interview).
Time frame: Enrollment to end of study participation at 4 months.
Evaluate intervention adherence, usability, and engagement metrics via mobile application
To evaluate the breathing intervention adherence, usability, and engagement metrics collected through the mobile application platform. These data will be used to identify barriers and facilitators to digital engagement, assess usability, and inform refinements to the intervention's delivery and technological infrastructure for future large-scale trials.
Time frame: Enrollment to end of treatment at 4 months.